FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for ...

Pittcon returns on 7–11 March 2026, bringing the global scientific community together at the Henry B. González Convention Center in San Antonio, Texas, USA. The Conference runs from 7–11 ...

Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s  Labguru electronic lab notebook (ELN) and inventory management platform ...

CD Bioparticles launches Magnetic Solid-Phase Extraction Particles to simplify complex sample preparation workflows NEW ...

From left to right: Chris Perkin, Executive Chairman of the Board (Altasciences), and Marie-Hélène Raigneau, Chief Executive Officer (Altasciences).

Robert Hettich conducts research in ORNL's biological mass spectrometry laboratory. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy Scientists at ...

Eurofins Viracor BioPharma Services is expanding its service portfolio with enhanced bioanalytical testing capabilities fully ...

Eurofins Viracor BioPharma Services, a long?standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant ...

EXTON, PA — Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc. (Nasdaq: FHL), has relocated its bioanalytical laboratory to a single, expanded facility near Milan, a move the ...

The role of medical labs is evolving. Driven by growing demands from aging populations, healthcare laboratory service providers are adopting lab automation and molecular platforms to boost processing ...

EXTON, Pa., Jan. 27, 2026 /PRNewswire/ -- We are pleased to communicate that Frontage Europe, a fully owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to ...

Introduction: Investigational immunomodulatory drugs are often initially investigated in healthy volunteers, which lack drug-target engagement biomarkers, hampering evaluation of pharmacodynamic ...